Dominik Bacher, founder and CEO at Bacher Zoppi, explains the latest changes in the commercialization stage of the healthcare industry and showcases the value proposition of Bacher Zoppi to successfully implement sustainable sales strategies.
After slowing in 2012-13, Mexico’s pharmaceutical sector is expected to grow on average 5.6 percent rising from USD 16.4 billion in 2013 to 21.5 billion in 2018. Could you please tell our international readers what steps the industry needs to take in terms of commercial optimization to keep performing at this level?
"Pharmaceutical companies have changed the targeting of their sales activities towards specialists and reduced the total number of sales representatives."
